PhotoMedex, Inc. (NASDAQ: PHMD) provides novel solutions designed for application in the areas of dermatology, therapeutic skin care and surgical products & services. The company is currently developing proprietary excimer laser and fiber-optic systems to treat dermatological applications such as psoriasis and vitiligo. PhotoMedex’s XTRAC® was the first FDA market-cleared excimer laser system designed to treat dermatological applications such as psoriasis and vitiligo. For further information, visit the Company’s web site at www.photomedex.com.
- 17 years ago
QualityStocks
PhotoMedex, Inc. (NASDAQ: PHMD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Adageis Brings Key Advantages in Pivot to Value-Based Healthcare
Adageis offers providers tools that simplify operations and improve financial performance as healthcare shifts further toward…
-
QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advancing Strategic Path in Resurging Market
Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is well positioned as platinum and palladium prices…
-
QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Sees 245% Surge in Juve Stabia Valuation Following Promotion Playoff Run
Brera Holdings (NASDAQ: BREA), an Ireland-based company executing a multi-club ownership strategy in global football,…